News | January 27, 2025
Granules India Q3 FY25 PAT drops 6% to Rs 118 Cr
The company said it voluntarily paused production at the Gagillapur plant in September 2024 for risk assessment on account of the USFDA observations
The company said it voluntarily paused production at the Gagillapur plant in September 2024 for risk assessment on account of the USFDA observations
PAT after MI is Rs. 41 crore which is 162% increase
Expand the scope of the Production-Linked Incentive (PLI) scheme and increase its allocation to cover more pharmaceutical products and raw materials
The project will provide additional support for late-stage development and licensure of pre-pandemic mRNA-based vaccines
Investment will fund expansion to meet rising demand for CRDMO services
This strategic move aims to address the increasing global demand for biologics, enhancing ProBioGen's ability to support partners from cell line development t
Consequent to this appointment, Sarosh Shetty ceases to be Interim CEO of ICH.
The cornerstone of the quality ecosystem is the implementation of the Quality Control Orders
The facility is equipped with state-of-the-art technology to produce high-quality lyophilized (freeze-dried) products
Immedica to commence a cash tender offer to acquire all issued and outstanding shares of Marinus for an enterprise value of approximately US$ 151 million
Subscribe To Our Newsletter & Stay Updated
